Keyvantage Wealth, LLC Merck & Co., Inc. Transaction History
Keyvantage Wealth, LLC
- $206 Billion
- Q1 2025
A detailed history of Keyvantage Wealth, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Keyvantage Wealth, LLC holds 5,020 shares of MRK stock, worth $386,439. This represents 0.22% of its overall portfolio holdings.
Number of Shares
5,020
Previous 5,245
4.29%
Holding current value
$386,439
Previous $522 Million
13.64%
% of portfolio
0.22%
Previous 0.37%
Shares
2 transactions
Others Institutions Holding MRK
# of Institutions
3,890Shares Held
1.93BCall Options Held
26.2MPut Options Held
23.5M-
Vanguard Group Inc Valley Forge, PA253MShares$19.4 Billion0.42% of portfolio
-
Black Rock Inc. New York, NY207MShares$16 Billion0.59% of portfolio
-
State Street Corp Boston, MA121MShares$9.28 Billion0.46% of portfolio
-
Wellington Management Group LLP Boston, MA81.7MShares$6.29 Billion1.46% of portfolio
-
Geode Capital Management, LLC Boston, MA59.7MShares$4.59 Billion0.43% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $195B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...